Medigen Biotechnology (Taiwan) Insiders
| 3176 Stock | TWD 34.75 0.45 1.28% |
Medigen Biotechnology employs about 18 people. The company is managed by 4 executives with a total tenure of roughly 19 years, averaging almost 4.0 years of service per executive, having 4.5 employees per reported executive. Recap of Medigen Biotechnology's management performance can provide insight into the venture performance.
| Bill Ou CFO CFO, Deputy General Manager |
| Wenlii Lin Insider Pres Bus |
Medigen |
Medigen Biotechnology Management Team Effectiveness
Medigen Biotechnology's management efficiency ratios could be used to measure how well Medigen Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.Medigen Biotechnology Workforce Comparison
Medigen Biotechnology is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 208. Medigen Biotechnology holds roughly 18.0 in number of employees claiming about 9% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Medigen Biotechnology Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Medigen Biotechnology Price Series Summation is a cross summation of Medigen Biotechnology price series and its benchmark/peer.
Medigen Biotechnology Notable Stakeholders
A Medigen Biotechnology stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medigen Biotechnology often face trade-offs trying to please all of them. Medigen Biotechnology's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medigen Biotechnology's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Bill Ou | CFO, Deputy General Manager | Profile | |
| Eugene Cheng | General Manager, Director | Profile | |
| Wenlii Lin | Pres Bus | Profile | |
| ShiChung Chang | Chairman Officer | Profile |
About Medigen Biotechnology Management Performance
The success or failure of an entity such as Medigen Biotechnology often depends on how effective the management is. Medigen Biotechnology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medigen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medigen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Medigen Biotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medigen Biotechnology. Check Medigen Biotechnology's Beneish M Score to see the likelihood of Medigen Biotechnology's management manipulating its earnings.
Medigen Biotechnology Workforce Analysis
Traditionally, organizations such as Medigen Biotechnology use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medigen Biotechnology within its industry.Medigen Biotechnology Manpower Efficiency
Return on Medigen Biotechnology Manpower
| Revenue Per Employee | 217.9M | |
| Revenue Per Executive | 980.5M | |
| Net Loss Per Employee | 2.9M | |
| Net Loss Per Executive | 13.2M |
Additional Tools for Medigen Stock Analysis
When running Medigen Biotechnology's price analysis, check to measure Medigen Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigen Biotechnology is operating at the current time. Most of Medigen Biotechnology's value examination focuses on studying past and present price action to predict the probability of Medigen Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigen Biotechnology's price. Additionally, you may evaluate how the addition of Medigen Biotechnology to your portfolios can decrease your overall portfolio volatility.